Fastfold AI Joins NVIDIA Inception

We’re excited to share that Fastfold AI has been accepted into NVIDIA Inception, a program designed to support startups transforming industries through advancements in AI and data science.

Our mission

At Fastfold AI, we are building next-generation tools to accelerate biological discovery. Our platform enables rapid protein folding predictions, structure-based drug design, and AI-driven analysis for molecular interactions. These capabilities help biotech and pharmaceutical teams move faster from raw sequences to actionable insight.

Why NVIDIA Inception Matters

Being part of NVIDIA Inception gives us access to:

• Technical guidance to enhance model training and inference at scale
• Resources to streamline high-throughput computational workflows
• Visibility in a global community of cutting-edge AI companies

“With the support of NVIDIA Inception, we’re better equipped to scale our platform and bring AI-native tools to life science teams worldwide,” said Julio Castellanos, CEO of Fastfold AI. “In high-throughput screening workflows, for example, we often need to make predictions for tens of thousands of clustered proteins. NVIDIA Inception is more than a growth enabler—it’s a catalyst for deeper innovation and a catalyst for scale.”

Looking Ahead

This milestone will help us continue building:

• Advanced pipelines for de novo protein generation
• Screening tools for therapeutics
• Scalable solutions for structural and interaction modeling

As we grow, our focus remains on enabling scientists to discover and validate hypotheses faster—unlocking new possibilities in drug development, disease research, and synthetic biology.

About NVIDIA Inception

NVIDIA Inception helps startups during critical stages of development, offering resources like deep learning training, cloud credits, and access to technical expertise. Each member receives a customized set of ongoing benefits to accelerate innovation and market impact.